The Oncological and Surgical Outcomes of Immediate Oncoplastic Breast Reconstruction With Contralateral Breast Adjustment.

Autor: Sahar O, Har Zvi R, Barsuk D, Barnea Y, Gelbart Pridan O, Hod K, Ben-David MA

Publikováno v: Aesthetic surgery journal [Aesthet Surg J] 2024 Sep 16; Vol. 44 (10), pp. 1055-1062.

Identifying the Variables for Oncoplastic Reconstruction: Preoperative Assessment Tool for Breast Conserving Treatment.

Autor: Meshulam-Derazon S; Department of Plastic Surgery and Burns, Rabin Medical Center, Petach Tikvah, Israel, affiliated to Sackler School of Medicine, Tel-Aviv University, 39th Jabutinsky St. Petah Tikva, 4941492, Tel Aviv, Israel., Yaacobi DS; Department of Plastic Surgery and Burns, Rabin Medical Center, Petach Tikvah, Israel, affiliated to Sackler School of Medicine, Tel-Aviv University, 39th Jabutinsky St. Petah Tikva, 4941492, Tel Aviv, Israel. Dafna.yaacobi@icloud.com., Ben-David MA; Radiation Oncology Department, Assuta Medical Center, Tel-Aviv, Israel AND Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel., Lvovsky A; Head of Forensic Identification Department, Israel Defense Forces, Medical Corps, Tel Aviv, Israel., Hadanny A; Yitzhak Shamir Medical Center, Affiliated with the Tel Aviv University School of medicine, Zriffin, Israel., Ganor O; Department of Plastic and Oral Surgery, Boston Children's Hospital, Boston, MA, USA.; Department of Surgery, Harvard Medical School, Boston, MA, USA., Amir A; Department of Plastic Surgery and Burns, Rabin Medical Center, Petach Tikvah, Israel, affiliated to Sackler School of Medicine, Tel-Aviv University, 39th Jabutinsky St. Petah Tikva, 4941492, Tel Aviv, Israel., Ad-El D; Department of Plastic Surgery and Burns, Rabin Medical Center, Petach Tikvah, Israel, affiliated to Sackler School of Medicine, Tel-Aviv University, 39th Jabutinsky St. Petah Tikva, 4941492, Tel Aviv, Israel., Wertman M; Department of Surgery, Kaplan Medical Center, Rehovot and the Hebrew University Medical School, Jerusalem, Israel.

Publikováno v: Aesthetic plastic surgery [Aesthetic Plast Surg] 2024 Jul; Vol. 48 (13), pp. 2439-2446. Date of Electronic Publication: 2023 Oct 23.

Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases.

Autor: Ugurluer G; Department of Radiation Oncology, Acibadem MAA University, School of Medicine, Istanbul, Turkey., Schneiders FL; Department of Radiation Oncology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, Netherlands., Corradini S; Department of Radiation Oncology, University Hospital, Ludwig-Maximilians-University Munich, Germany., Boldrini L; Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Largo Agostino Gemelli 8, Rome, Italy., Kotecha R; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA., Kelly P; Department of Radiation Oncology, Orlando Health Cancer Institute, Orlando, FL, USA., Portelance L; Department of Radiation Oncology, University of Miami, Miami, FL, USA., Camilleri P; Radiation Oncology, GenesisCare-Oxford, Oxford, UK., Ben-David MA; Department of Radiation Oncology, Assuta Medical Center, Tel Aviv, Israel.; Faculty of Health Science, Ben-Gurion University, Beer Sheva, Israel., Poiset S; Department of Radiation Oncology, Sidney Kimmel Cancer Center of Thomas Jefferson University, Philadelphia, PA, USA., Marschner SN; Department of Radiation Oncology, University Hospital, Ludwig-Maximilians-University Munich, Germany., Panza G; Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Largo Agostino Gemelli 8, Rome, Italy., Kutuk T; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA., Palacios MA; Department of Radiation Oncology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, Netherlands., Castelluccia A; Department of Radiation Oncology, Ospedale San Pietro Fatebenefratelli di Roma, Rome, Italy., Zoto Mustafayev T; Department of Radiation Oncology, Acibadem Maslak Hospital, Istanbul, Turkey., Atalar B; Department of Radiation Oncology, Acibadem MAA University, School of Medicine, Istanbul, Turkey., Senan S; Department of Radiation Oncology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, Netherlands., Ozyar E; Department of Radiation Oncology, Acibadem MAA University, School of Medicine, Istanbul, Turkey.

Publikováno v: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2024 Feb 29; Vol. 46, pp. 100756. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).

Treatment-Induced Bone Marrow Enhancement at MRI in Breast Cancer Patients Receiving Granulocyte-Colony Stimulating Factor Adjunct to Chemotherapy.

Autor: Sorin V; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; Department of Diagnostic Imaging, Chaim Sheba Medical Center, Ramat Gan, Israel. Electronic address: verasrn@gmail.com., Bokov I; Hadassah Medical School, The Hebrew University, Jerusalem, Israel; Department of Diagnostic Imaging, Kaplan Medical Center, Rehovot, Israel., Haisraely O; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; Radiation Oncology Department, Chaim Sheba Medical Center, Ramat Gan, Israel., Ben-David MA; Ben-Gurion University of the Negev, Beer Sheva, Israel; Assuta Medical Center, Tel-Aviv, Israel., Faermann R; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; Department of Diagnostic Imaging, Chaim Sheba Medical Center, Ramat Gan, Israel., Sklair-Levy M; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; Department of Diagnostic Imaging, Chaim Sheba Medical Center, Ramat Gan, Israel.

Publikováno v: Academic radiology [Acad Radiol] 2023 Sep; Vol. 30 Suppl 2, pp. S9-S15. Date of Electronic Publication: 2023 Jun 03.

Outcome of the first 200 patients with prostate cancer treated with MRI-Linac at Assuta MC.

Autor: Gelbart Pridan O; The Adelson School of Medicine, Ariel University, Ariel, Israel., Ben David MA; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel., Zalmanov S; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel., Lipski Y; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel., Grinberg V; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel., Levin D; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel., Apter S; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Guindi M; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.; Innovation Division, Assuta Medical Center, Tel Aviv, Israel., Epstein D; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel., Radus R; Radiation Oncology Department, Rabin Medical Center, Petah-Tikva, Israel., Arsenault O; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel., Hod K; Department of Academy and Research, Assuta Medical Center, Tel Aviv, Israel., Tamami Q; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel., Pfeffer R; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Mar 23; Vol. 13, pp. 1151256. Date of Electronic Publication: 2023 Mar 23 (Print Publication: 2023).